Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedF-1815-2017

Supplement recall · April 5, 2017

Baidyanath brand Arogyavardhini Bati recall

Why: The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Baidyanath brand Arogyavardhini Bati, Dietary Supplement, 80 Tablets -- Product of India --- Mfd in India - Shree Baidyanath Ayurved Bhawan (P) Ltd. 1 Gupta Lane, Kolkata 700006

Lots / codes

Batch No. 018, Expiry Date 03/2017

Quantity
183 bottles
Company
Butala Emporium, Inc., Jackson Heights, NY
Distribution
NY (via 3 retail stores) and directly to 26 individual consumers (CT, FL, HI, NJ, PA, OH, MA, District of Columbia, VT & PR)
Initiated
August 27, 2015 · Voluntary: Firm initiated
Classified
March 30, 2017
Reported
April 5, 2017
Ended
June 13, 2018
How notified
Telephone

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.